Introduction
============

Free-radical scavenging capacity or antioxidant capacity in serum is thought to be an indicator of the body's defensive capacity against oxidative stress.^([@B1],[@B2])^ Various methods have been proposed to evaluate the scavenging capacity in biological specimens.^([@B3]--[@B8])^ Most methods were categorized as indirect methods, where the probe's free-radical damage was indirectly monitored and the protection capacity of the specimen against the probe damage was evaluated. However, free radical species that was responsible for the damage has been rarely identified. In contrast, direct methods adopt electron spin resonance (ESR) technique to directly quantify the change in free radical concentration by the presence of the specimen, from which its free-radical scavenging capacity was calculated.^([@B9])^ Previously, using enzymatic superoxide generating systems, the scavenging capacity in biological fluid has been measured as superoxide dismutase (SOD)-like activity.^([@B10])^ In other studies, serum hydroxyl radical scavenging capacity has been measured with the use of the Fenton reaction; i.e., ferrous iron plus hydrogen peroxide as a free radical source.^([@B9])^ We used iron-free photochemical hydroxyl radical generating system and determined serum hydroxyl radical scavenging capacity in chronic kidney disease (CKD) patients.^([@B11])^ The results indicated that there was nearly a 40% decrease in hydroxyl radical scavenging capacity among the CKD group as compared with the healthy control group. Furthermore, in the same study, it was shown that the scavenging capacity was restored to the healthy level, immediately after hemodialysis treatment.

Obviously, the magnitude of free radical scavenging capacity is dependent on the kind of free radical species to be scavenged.^([@B12])^ However, a majority of previous direct-method studies concerned hydroxyl radical or superoxide radical. The significance of the scavenging capacity change in hydroxyl and superoxide radicals remains unclear because the mechanism by which these species may be causal to the disease is largely unknown. Moreover, free radical species that is involved in biological activity is not necessarily limited to hydroxyl or superoxide radical. For example, hepatotoxic carbon tetrachloride has been shown to produce trichloromethyl and other free radicals *in vivo* and *in vitro*.^([@B13])^ Thus, we believe that the knowledge on the antioxidant capacity against various free radical species may expand understanding of the change in the antioxidant capacity in the specific disease.

In the scavenging capacity measurement, it has been difficult to establish dependable free radical sources, especially when the free radical is short-lived. Stable free radical such as 2,2-diphenyl-1-pycrylhydrazyl (DPPH) has been used in biological samples;^([@B14])^ however, DPPH is hardly related to biological systems. *In situ* photolysis of the free radical precursor in the ESR sample-cavity has been shown to be a convenient means to produce a finite amount of free radicals if the light-intensity and illumination-time are well-controlled.^([@B15])^ In this study, by selecting appropriate free radical precursors or photo-sensitizers, six different free radical species, namely hydroxyl radical, superoxide radical, alkoxyl radical, alkylperoxyl radical, alkyl radical, and singlet oxygen were produced with the common photolytic procedures. Produced free radicals were identified and quantified with ESR spin trapping method.^([@B15])^ In the presence of serum, the ESR signal intensity was decreased, depending on the magnitude of its scavenging capacity against the specific free radical.^([@B11],[@B12])^ Thus, the objective of this study was to establish a method to determine scavenging capacities against multiple free radical species and seek for the possibility of using this method for medical purposes.

Materials and Methods
=====================

Materials and equipment
-----------------------

Light sources, illumination times, precursors and photo-sensitizers used in this study are listed in Table [1](#T1){ref-type="table"}. Hydrogen peroxide, riboflavin, 2,2\'-azobis (2-amidinopropane) hydrochrolide (AAPH), *t*-butyl hydroperoxide, dimethyl sulfoxide (DMSO), rosebengal, and 4-hydroxy-2,2,6,6-tetramethylpiperidine (4-OH-TEMP) were purchased from Tokyo Chemical Industry (Tokyo, Japan) and used as received. Buffers and biochemical reagents were obtained from Wako Pure Chem. Ind. Ltd. (Osaka, Japan). The spin trap CYPMPO was obtained from Radical Research Inc. (Hino, Japan).^([@B22])^

UV light source was a 200 W medium-pressure mercury/xenon arc (RUVF-203SR UV illuminator, Radical Research Inc.), where UV-visible light was guided through a quartz light-guide into the ESR sample cavity. ESR spectrometer employed was a JEOL FR-80 (Akishima, Japan) equipped with 100 kHz field modulation and a WIN-RAD operation software (Radical Research Inc.). Typical spectrometer settings were: field modulation width 0.1 mT; microwave power 6 mW; field scan width and rate ± 7.5 mT/2 min; time constant 0.1 s.

Human subject
-------------

All human subject procedures were conducted with individual consent form and strictly following the protocol that had been approved by Asao Clinic Human Subject Use Committee. Blood was obtained from chronic kidney disease (CKD) patients undergoing stable maintenance hemodialysis (HD) (*n* = 45; 20 females and 25 males; average age 65 ± 13; average HD durations 110 ± 82 months) and healthy volunteers (*n* = 30; 20 females and 10 males; average age 35 ± 15). The causes of CKD were as follows; 26 patients had chronic glomerulonephritis, 7 had diabetic nephropathy and 12 had nephrosclerosis. Serum was separated and stored in the --30°C freezer until use. HD patients' blood was collected before hemodialysis.

Methods of free radical production
----------------------------------

Each free radical species was produced via *in situ* illumination of UV/visible light from an RUVF-203SR UV illuminator to a buffer solution of corresponding free radical precursor or sensitizer. Table [1](#T1){ref-type="table"} shows the list of precursors/sensitizers and the detailed conditions for the photochemical free radical production for all six species along with previous publications for those production methods.^([@B15]--[@B21])^ For example, hydroxyl radical was produced by illuminating 5 s un-filtered UV light from the illuminator to a sodium phosphate buffer (80 mM) solution of hydrogen peroxide (10 mM) and CYPMPO (10 mM), immediately followed by the recording of the ESR spectrum.

Measurement of serum free radical scavenging capacity
-----------------------------------------------------

In the absence of serum, the signal intensity I~0~ of the selected ESR line was recorded, and in the presence of serum, the intensity I was again recorded. Using I~0~ and I, the free radical scavenging capacity *k*~serum~/*k*~CYPMPO~was calculated according to the following equation:^([@B11],[@B12])^

where \[Serum\]~0~ denotes the percent concentration of serum divided by 100, and \[ST\]~0~ denotes CYPMPO concentration in mM unit. Therefore, *k*~serum~/*k*~CYPMPO~ was calculated in the mM CYPMPO equivalent unit. Typically, scavenging capacity was determined in 5 or 10% buffer solution of serum and the total volume of the sample solution was approximately 0.2 mL.

Statistical analysis
--------------------

At the designated conditions, three sample solutions were separately prepared and separate measurements were made. The raw data for *k*~serum~/*k*~CYPMPO~ were averaged and expressed with standard deviation (SD). Statistical test for the difference between the CKD group (*n* = 45) and the control group (*n* = 30) was performed using the Student's *t* test.

Results
=======

All free radical species except singlet oxygen were quantified with the ESR spin trapping method using CYPMPO as a spin trap. CYPMPO has been shown to have lower toxicity and better superoxide trapping performance in biological systems than similar spin traps.^([@B22]--[@B24])^ The spin-trapping reaction to capture the free radical R by CYPMPO proceeds as follows:

The ESR spectra of the spin adducts (the product in the above equation) for ^•^OH, O~2~^•−^, RO^•^, ROO^•^, and R are shown in Fig. [1](#F1){ref-type="fig"} A--E. Each spectrum was assigned to corresponding radical adduct and the hyperfine coupling constants (HFCC) for the ESR spectra were determined with computer spectrum simulation using an ESR simulation software in WIN-RAD system software (Table [2](#T2){ref-type="table"}). Singlet oxygen was produced by illuminating visible light to the solution containing the photo-sensitizer rosebengal (Table [1](#T1){ref-type="table"}). Singlet oxygen reacts with 4-OH-TEMP, forming the TEMPOL radical (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) that shows three line ESR spectrum (Fig. [1](#F1){ref-type="fig"}F) and the signal amplitude was proportional to the amount of singlet oxygen. A singlet-oxygen quencher, glutathione reduced form (GSH) was used to confirm the specificity.^([@B25])^

In the presence of serum, the signal amplitude decreased, from which the scavenging capacity (rate) was calculated with Eq. (1). Thus, Table [3](#T3){ref-type="table"} lists relative scavenging rates (*k*~serum~/*k*~spin\ trap~) of the serum for all six free radical species. The radar chart in Fig. [2](#F2){ref-type="fig"} illustrates percent scavenging-rate in the CKD group with respect to the control group. There were no differences of serum scavenging capacities among patients with DM or non-DM HD patients.

In Table [3](#T3){ref-type="table"}, the serum scavenging capacity *k*~serum~/*k*~CYPMPO~ is listed relative to that of 1 mM CYPMPO, i.e., in the mM-CYPMPOeq unit. These numbers were converted into the unit equivalent to known pure scavengers, such as glutathione (GSH), superoxide dismutase (SOD), trolox, and α-lipoic acid (LA). Thus, we measured *k*~GSH~/*k*~CYPMPO~ for ^•^OH and ^1^ΔO~2~, (=0.045 and 0.28, respectively), *k*~SOD~/*k*~CYPMPO~ for O~2~^•−^ (=0.0237), *k*~TROLOX~/*k*~CYPMPO~, for RO^•^ (=1.11), and*k*~LA~/*k*~CYPMPO~ for ROO^•^ (=0.105). These conversion factors were used to calculate *k*~serum~**/***k*~SCAVENGER~and the results were listed in the bottom panel of Table [3](#T3){ref-type="table"}.

Discussion
==========

In the present study, we propose the multiple free-radical scavenging method (MULTIS) to measure serum scavenging capacities against six biologically relevant free radical species. The advantage of this method is to use the same experimental procedures to produce all six different free radical species. Briefly, the photolytic degradations of precursors were used in the case of hydroxyl, alkoxyl, and alkylperoxyl radicals. Alkyl (methyl) radical was produced from the photolysis of dimethyl sulfoxide (DMSO) plus hydrogen peroxide.^([@B19])^ Photo-sensitizers, riboflavin and rosebengal were used for the production of superoxide radical and singlet oxygen, respectively. Unlike other methods of free radical generation, all the six reactions would occur only when UV or visible light was turned on and their signal-intensities/concentrations grew proportional to the illumination time at least in the early stage of illumination. Such facile handling of the reaction systems clearly differentiates this method from other free-radical generating systems like the hypoxanthine-xanthine oxidase system, the Fenton reaction system, or the fluorescence-based ORAC method.^([@B4])^

The results indicated that there were statistically significant shifts in the profile of the CKD group from the control group, except alkylperoxyl radical (Abstract, Table [3](#T3){ref-type="table"}, and Fig. [2](#F2){ref-type="fig"}). Such changes are visibly obvious in radar chart illustration shown in Fig. [2](#F2){ref-type="fig"}. Scavenging capacity decreases in hydroxyl radical (73 ± 12% with respect to healthy control group), methyl radical (26 ± 14%) and singlet oxygen (57 ± 18%) were eminent. It is of interest to note that slight but statistically significant increases of the scavenging capacities in the CKD group were found in superoxide radical, t-butoxyl radical, and t-butylperoxyl radical. Although disease conditions usually incapacitate defensive mechanism against oxidative stress the scavenging-capacity increase may indicate that certain defensive mechanisms had been induced and enhanced in CKD. When more data will be available for various diseases such illustration would be potentially useful in judging the state of the specific disease.

It is quite possible that serum antioxidant capacity is readily modified by the disease state. Recently Chen *et al.*^([@B26])^ reported that the scavenging capacity changes in the plasma of CKD patients (*n* = 20) against singlet-oxygen chemiluminescence, hypochlorite, hydrogen peroxide, and hydroxyl radical (FRAP assay). Scavenging capacities for hydrogen peroxide and singlet oxygen have been shown to decrease by approximately 20% in pre-hemodialytic plasmas. But, all parameters showed significant decreases in the post-hemodialytic plasmas. Although there was no clear interpretation for these changes the approach that was adopted in that study was in line with the present study. However, the identification of the mechanism by which serum or plasma antioxidant capacity is modified by the disease would be difficult and time-consuming and could be a futile effort. There must be enormous number of factors that can influence serum free radical scavenging capacity. Even a slight change in water- or protein-content in the serum would have caused the shift in the scavenging capacity.^([@B10])^ Instead of pursuing the cause of shift in the scavenging capacity, we took a practical standpoint and directed this work for future applications. A remarkable radar chart display in Fig. [2](#F2){ref-type="fig"} seems to support the direction.

In conclusion, we have proposed the MULTIS method to demonstrate scavenging-profile deviation in a cohort of CKD patients. It is likely that MULTIS profile would be disease specific, thus this method potentially become a tool for diagnosis or prognosis.
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CKD

:   chronic kidney disease

CYPMPO

:   5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide

DM

:   diabetes mellitus

DMSO

:   dimethyl sulfoxide

ESR

:   electron spin resonance

GSH

:   glutathione reduced form

HD

:   hemodialysis

HFCC

:   hyperfine coupling constants

α-LA

:   α-lipoic acid

MULTIS

:   multiple-radical scavenging

4-OH-TEMP

:   4-hydroxy-2,2,6,6-tetramethylpiperidine

ORAC

:   oxygen radical absorbance capacity

SOD

:   superoxide dismutase

![ESR spectra of various spin adducts produced after photolysis of precursors/sensitizers (Table [1](#T1){ref-type="table"}): A) hydroxyl radical adduct of CYPMPO; B) superoxide radical adduct of CYPMPO; C) t-butoxyl radical adduct of CYPMPO; D) t-butyl peroxyl radical adduct of CYPMPO; E) methyl radical adduct of CYPMPO; and F) TEMPOL radical formed after the reaction of singlet oxygen with 4-OH-TEMP.](jcbn11-113f01){#F1}

![A radar chart illustration of the relative scavenging capacity data listed in Table [3](#T3){ref-type="table"}. Percent changes in the capacity of the CKD group (thick lines) are shown with respect to the control group. Error bars are shown in each free radical species and the numbers marked with asterisk showed statistically significant difference from the control group.](jcbn11-113f02){#F2}

###### 

Photolytic production methods of multiple free radical species

  Free Radical   Precursor/Sensitizer               Light source^a^   Filter      Wavelength range   Illumination period   Spin trap   Reference
  -------------- ---------------------------------- ----------------- ----------- ------------------ --------------------- ----------- ------------
  ^•^OH          hydrogen peroxide (10 mM)          RUVF-203SR        none        300--400 nm        5 s                   CYPMPO      \[15\]
  O~2~^•−^       riboflavin (20 µM)                 RUVF-203SR        band-path   500--600 nm        60 s                  CYPMPO      \[16, 17\]
  *t*-BuO^•^     AAPH (1 mM)                        RUVF-203SR        none        300--400 nm        5 s                   CYPMPO      \[7\]
  *t*-BuOO^•^    *t*-butylhydro-peroxide (10 mM)    RUVF-203SR        none        300--400 nm        5 s                   CYPMPO      \[18\]
  CH~3~^•^       H~2~O~2~ (100 mM) + DMSO (10 mM)   RUVF-203SR        none        300--400 nm        5 s                   CYPMPO      \[19\]
  ^1^ΔO~2~       rosebengal^b^ (200 µM)             RUVF-203SR        band-path   500--600 nm        60 s                  4-OH-TEMP   \[20\]

^a^ RUVF-203SR illuminator delivers UV-visible light from a 200 W medium pressure Hg/Xe arc to the ESR cavity via the quartz optical-guide. Light intensity was approximately b. 4000 mW/cm^2^ for UV range and 1800 mW/cm^2^ for visible range. ^b^ Pterin derivatives, such as 6-formylpterin or 6-carboxylpterin can be used instead of rosebengal.^([@B21])^

###### 

Hyperfine coupling constants of spin adducts.

  Free Radical                              HFCC/mT   Assignment          
  ----------------------------------------- --------- ------------ ------ -------------------
  Hydroxyl, ^•^OH                           1.37      1.37         4.88   CYPMPO-OH^a^
                                            1.23      1.35         4.70   CYPMPO-OH^a^
  Superoxide, O~2~^•−^                      1.11      1.26         5.25   CYPMPO-O~2~^−b^
                                            1.04      1.27         5.10   CYPMPO-O~2~^−b^
  *t*-Butoxyl, *t*-BuO^•^ (Alkoxyl)         1.24      1.36         4.80   CYPMPO-OBu^c^
  *t*-Butoxyl, *t*-BuOO^•^ (Alkylperoxyl)   1.35      1.45         5.05   CYPMPO-OOBu^d^
  Methyl, CH~3~^•^ (Alkyl)                  2.05      1.51         4.90   CYPMPO-CH~3~
  Singlet Oxygen, ^1^ΔO~2~                            1.50                TEMPOL radical^e^

^a^ Diastereomers.^([@B14])^ ^b^ Diastereomers.^([@B14])^ ^c^ Actual structure of BuO^•^ is H~2~N(HN)C-C(CH~3~)~2~-O^•^.^([@B7])^ ^d^ Actual structure of BuOO^•^ is (CH~3~)~3~C-OO^•^. ^e^ TEMPOL radical = 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl radical.

###### 

Relative scavenging capacity of the serum as measured for multiple free radical species

                               Free Radical                                                                                                                                                                                   
  ---------------------------- -------------------------------- ---------------------------------- -------------------------------------- --------------------------------------- ------------------------------------------- --------------------------------
  CKD (*n* = 45)               0.31 ± 0.05                      0.38 ± 0.21                        1.25 ± 0.31                            0.16 ± 0.05                             0.09 ± 0.05                                 6.94 ± 2.25
  percent vs control           73 ± 12%                         158 ± 50%                          121 ± 30%                              123 ± 32%                               26 ± 14%                                    57 ± 18%
  healthy control (*n* = 30)   0.42 ± 0.12                      0.24 ± 0.07                        1.03 ± 0.07                            0.13 ± 0.04                             0.35 ± 0.14                                 12.20 ± 2.07
                                                                                                                                                                                                                              
                               *k*~serum~*/k*~GSH~ *mM-GSHeq*   *k*~serum~*/k*~SOD~ *U/ml-SODeq*   *k*~serum~*/k*~TROLOX~ *mM-TROLOXeq*   *k*~serum~*/k*~LA~ *mM-*α*-LA*^a^*eq*   *k*~serum~*/k*~CYPMPO~ *mM-CYPMPO*^b^*eq*   *k*~serum~*/k*~GSH~ µ*M-GSHeq*
                                                                                                                                                                                                                              
  CKD (*n* = 45)               6.8 ± 1.1                        16.0 ± 6.0                         1.13 ± 0.28                            1.52 ± 0.52                             0.09 ± 0.05                                 24.8 ± 7.9
  healthy control (*n* = 30)   9.4 ± 2.8                        10.1 ± 1.9                         0.93 ± 0.06                            1.24 ± 0.47                             0.35 ± 0.14                                 43.6 ± 7.3

Top panel: Scavenging capacities of the serum are calculated relative to that of CYPMPO (*k*~serum~/*k*~CYPMPO~ in mM-CYPMPO eq unit). For singlet oxygen, its quencher 4-OH-TEMP was used as a detection reagent and the capacity is listed as *k*~serum~/*k*~TEMP~. Bottom panel: Scavenging capacities are converted into the equivalent units to pure scavengers. ^a^ α-lipoic acid. ^b^ There is no known scavengers for alkyl radical (R).
